{
  "abstract": "The aryl hydrocarbon receptor (AhR) is a transcription factor activated by ligands, which participates in multiple environmental, microbial, and metabolic signals and plays a crucial role in maintaining homeostasis. In the past, AhR was regarded as a receptor for environmental toxins, several studies in recent years have indicated a potentially significant association between AhR and bone and joint health. This review systematically describes AhR signaling pathways (including canonical and non-canonical pathways) and its ligands, and focuses on the direct regulatory role of AhR in osteoblast and osteoclast function. Additionally, this review deeply explores the immunoregulatory role of AhR in T cells and macrophages, as well as how AhR-mediated interactions between immune cells and bone cells shape the bone immune microenvironment. In addition, this review systematically reviews the mechanisms of tryptophan metabolites as AhR ligands regulating bone metabolism through the gut-immune-bone axis, and comprehensively evaluates the pathological significance of AhR in bone and joint diseases such as osteoarthritis, osteoporosis, and rheumatoid arthritis. Finally, this review explores AhR-targeted therapeutic strategies and the challenges they face, providing a new theoretical basis and viable research directions for the targeted treatment of bone and joint diseases.",
  "abstract_shown": true,
  "affiliations": [],
  "article_type": "Review",
  "arxiv": null,
  "author_total": 6,
  "authors": [
    {
      "name": "Dan Ren"
    },
    {
      "name": "Zeyue Zhu"
    },
    {
      "name": "Pengxing Cai"
    },
    {
      "name": "Jiquan Shen"
    },
    {
      "name": "Bo Wang"
    },
    {
      "name": "Hongliang Zhang"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/c3qdc1y53cfvj.bib",
  "cited_by": 0,
  "doi": "10.3389/fimmu.2026.2008416",
  "fulltext_url": null,
  "id": "c3qdc1y53cfvj",
  "issns": [
    "1664-3224"
  ],
  "landing_url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.2008416",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "feed-journal",
      "biology/immunology"
    ]
  ],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-12",
  "publisher": "Frontiers Media SA",
  "ris": "https://research.draconitic.com/paper/c3qdc1y53cfvj.ris",
  "sources": [
    {
      "first_seen": "2026-11-12T12:20:57Z",
      "native_id": "10.3389/fimmu.2026.2008416",
      "source": "feed-frontiers",
      "url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.2008416"
    },
    {
      "first_seen": "2026-11-12T12:22:47Z",
      "native_id": "10.3389/fimmu.2026.2008416",
      "source": "crossref",
      "url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.2008416/full"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "feed-journal:biology/immunology",
      "subfield": "immunology"
    }
  ],
  "title": "The aryl hydrocarbon receptor at the osteoimmune interface: from bone homeostasis to degenerative, metabolic, and inflammatory disorders",
  "title_text": "The aryl hydrocarbon receptor at the osteoimmune interface: from bone homeostasis to degenerative, metabolic, and inflammatory disorders",
  "type": "peer-reviewed",
  "updated_at": "2026-11-14T00:20:56Z",
  "url": "https://research.draconitic.com/paper/c3qdc1y53cfvj",
  "venue": "Frontiers in Immunology",
  "versions": []
}